DE69126270D1 - Transdermale therapeutische Zubereitungen - Google Patents

Transdermale therapeutische Zubereitungen

Info

Publication number
DE69126270D1
DE69126270D1 DE69126270T DE69126270T DE69126270D1 DE 69126270 D1 DE69126270 D1 DE 69126270D1 DE 69126270 T DE69126270 T DE 69126270T DE 69126270 T DE69126270 T DE 69126270T DE 69126270 D1 DE69126270 D1 DE 69126270D1
Authority
DE
Germany
Prior art keywords
transdermal therapeutic
polymeric matrix
therapeutic preparations
cutaneous
polymeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69126270T
Other languages
English (en)
Other versions
DE69126270T2 (de
Inventor
Fabio Carli
Luca Dobetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adare Pharmaceuticals SRL
Original Assignee
Vectorpharma International SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectorpharma International SpA filed Critical Vectorpharma International SpA
Publication of DE69126270D1 publication Critical patent/DE69126270D1/de
Application granted granted Critical
Publication of DE69126270T2 publication Critical patent/DE69126270T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
DE69126270T 1990-10-17 1991-10-15 Transdermale therapeutische Zubereitungen Expired - Fee Related DE69126270T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02176690A IT1243745B (it) 1990-10-17 1990-10-17 Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.

Publications (2)

Publication Number Publication Date
DE69126270D1 true DE69126270D1 (de) 1997-07-03
DE69126270T2 DE69126270T2 (de) 1997-12-04

Family

ID=11186565

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69126270T Expired - Fee Related DE69126270T2 (de) 1990-10-17 1991-10-15 Transdermale therapeutische Zubereitungen

Country Status (8)

Country Link
US (1) US5582836A (de)
EP (1) EP0481443B1 (de)
AT (1) ATE153538T1 (de)
DE (1) DE69126270T2 (de)
DK (1) DK0481443T3 (de)
ES (1) ES2104642T3 (de)
GR (1) GR3024567T3 (de)
IT (1) IT1243745B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
CA2166780A1 (en) * 1993-07-08 1995-01-19 Ooi Wong Monolithic matrix transdermal delivery system
EP0708627B1 (de) * 1993-07-09 2000-02-02 Cygnus, Inc. Verfahren und vorrichtung für die transdermale oder transbuccale therapeutische verabreichung von nikotinsubstituten
DE4338414C1 (de) * 1993-11-10 1995-03-16 Linde Ag Verfahren zur Herstellung linearer Olefine
AU4761196A (en) * 1995-01-19 1996-08-07 Cygnus, Inc. Polymer adhesive formulation containing sorbent particles
FR2735024B1 (fr) * 1995-06-08 1997-11-28 Sanofi Sa Dispositif d'administration cutanee d'un produit medicamenteux ou cosmetique.
US5882675A (en) * 1996-03-09 1999-03-16 Nitto Denko Corporation Percutaneous absorption preparation
EP0971662A1 (de) * 1996-10-30 2000-01-19 TheraTech, Inc. Fettsäureester von glycolsäure und deren salze als penetrationsverstärker
US20060141036A1 (en) * 1997-12-12 2006-06-29 Andrx Labs Llc HMG-CoA reductase inhibitor extended release formulation
US6344218B1 (en) 1998-11-23 2002-02-05 The Procter & Gamble Company Skin deodorizing and santizing compositions
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
US20040147534A1 (en) * 2003-01-23 2004-07-29 Foote Mary Ann Topical composition and method for treating occlusive wounds
DE10358747A1 (de) * 2003-12-12 2005-07-07 Lts Lohmann Therapie-Systeme Ag Darreichungsform basierend auf vernetzten hydrophilen Polymeren
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US9205062B2 (en) 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
EP1616581B1 (de) * 2004-06-18 2009-12-23 Nippon Shokubai Co., Ltd. Wasserabsorbierende Harzzusammensetzung und Verfahren zur Herstellung derselben
TWI344469B (en) 2005-04-07 2011-07-01 Nippon Catalytic Chem Ind Polyacrylic acid (salt) water-absorbent resin, production process thereof, and acrylic acid used in polymerization for production of water-absorbent resin
GB2431104A (en) * 2005-10-10 2007-04-18 Univ Greenwich Microgel particles grafted to a substrate
US7888422B2 (en) 2005-11-09 2011-02-15 Mylan Technologies Inc. Long-wearing removable pressure sensitive adhesive
GB0524958D0 (en) * 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents
TWI394789B (zh) 2005-12-22 2013-05-01 Nippon Catalytic Chem Ind 吸水性樹脂組成物及其製造方法、吸收性物品
EP1837348B9 (de) 2006-03-24 2020-01-08 Nippon Shokubai Co.,Ltd. Wasserabsorbierendes Harz und Verfahren zu seiner Herstellung
DE102006026578B4 (de) 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
US9017301B2 (en) * 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner
US20110033515A1 (en) * 2009-08-04 2011-02-10 Rst Implanted Cell Technology Tissue contacting material
CN102548654A (zh) 2009-09-29 2012-07-04 株式会社日本触媒 颗粒状吸水剂及其制造方法
CA2807225A1 (en) * 2010-08-06 2012-02-09 Miho Maeda Pharmaceutical preparation for controlling water-soluble drug release
DE102011090178A1 (de) 2011-12-30 2013-07-04 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit geringer Neigung zur Spontankristallisation
EP3267982A4 (de) * 2015-03-13 2018-11-07 Amneal Pharmaceuticals LLC Transdermales abgabesystem für fentanyl
CA3028436A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
KR102508993B1 (ko) * 2016-07-27 2023-03-10 코리움, 인크. 메만틴 경피 송달 시스템

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US5045319A (en) * 1985-02-25 1991-09-03 Rutgers, The State University Of New Jersey Transdermal dosage unit, system and process
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
US4615699A (en) * 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
US4749574A (en) * 1986-04-14 1988-06-07 Fujisawa Pharmaceutical Co., Ltd. Sustained-release transdermal delivery preparations
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US5001139A (en) * 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
IT1216570B (it) * 1988-04-08 1990-03-08 Vectorpharma Int Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
IT1230566B (it) * 1988-10-17 1991-10-28 Vectorpharma Int Farmaci poco solubili supportati su sostanze polimeriche in forma atta all'aumento della velocita' di dissoluzione
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5002773A (en) * 1989-09-29 1991-03-26 Marion Merrell Dow Inc. Transdermal delivery of (+) (2S,3S)-3-acetoxy-8-chloro-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5H)-one
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency

Also Published As

Publication number Publication date
GR3024567T3 (en) 1997-12-31
ATE153538T1 (de) 1997-06-15
EP0481443A1 (de) 1992-04-22
IT1243745B (it) 1994-06-21
US5582836A (en) 1996-12-10
DK0481443T3 (da) 1997-12-22
ES2104642T3 (es) 1997-10-16
IT9021766A1 (it) 1992-04-17
DE69126270T2 (de) 1997-12-04
EP0481443B1 (de) 1997-05-28
IT9021766A0 (it) 1990-10-17

Similar Documents

Publication Publication Date Title
DE69126270T2 (de) Transdermale therapeutische Zubereitungen
ES2125380T3 (es) Dispositivo medico para la administracion de ingredientes activos o medicamentos a dosis muy bajas, en especial medicamentos homeopaticos.
DE59009495D1 (de) Oestrogenhaltiges Wirkstoffpflaster.
DE3685895T2 (de) Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
ATE113650T1 (de) Ausgewählte stämme von lactobacillus enthaltende pharmazeutische zusammensetzungen.
DE59310399D1 (de) Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
IT8719064A0 (it) Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive.
DE69815094D1 (de) 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen
ATE86249T1 (de) Thiazolderivate mit aktivitaet auf das cholinergische system, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ES2058651T3 (es) Uso derivados de guanidina para la fabricacion de un medicamento con actividad antagonista de npy.
DE68917499D1 (de) Catechol-Derivate und sie enthaltende pharmazeutische Präparate.
DK0387693T3 (da) Transdermalt system med trinvis afgivelse af virksomme stoffer og anvendelse til lokal eller systemisk, kosmetisk udlevering af virksomme stoffer
DE68902300T2 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
ES2053528T3 (es) Composicion farmaceutica que comprende un medicamento y un polimero hinchable en agua.
EP0380989A3 (en) Plaster for transdermal administration
DE69012031T2 (de) Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung.
ITMI911950A1 (it) Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
DE68903389T2 (de) Kautschuk fuer medizinische oder pharmazeutische artikel.
DK0626173T3 (da) Aerosolpræparat indeholdende fusafungin
ITMI911845A1 (it) Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.
MX9200400A (es) Composicion farmaceutica que contiene polimeros aromaticos biologicamente activos
NO911470L (no) Sammensetning og behandling med biologisk aktive peptiderog visse anioner.
DE69111530T2 (de) Pyridincarbonsäure-Amid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: EURAND INTERNATIONAL S.P.A., MAILAND/MILANO, IT

8339 Ceased/non-payment of the annual fee